The CMS Health Equity Index is a game-changing tool from the Centers for Medicare & Medicaid Services that tracks how well Medicare Advantage and Part D plans support members with social risk factors. It spotlights performance for individuals facing challenges …
Acromegaly presents a diagnostic and management challenge due to its gradual onset, diverse symptoms, and complex treatment landscape. Delays in diagnosis and suboptimal care lead to prolonged morbidity and increased mortality. However, emerging therapies, including novel oral options, offer new …
Pre-exposure prophylaxis (PrEP) is an established and highly effective method of preventing sexually transmitted human immunodeficiency virus (HIV) infections and has been instrumental in declining incidence rates. Adherence and access to HIV prevention still pose challenges due to stigma and …
Pre-exposure prophylaxis (PrEP) is an established and highly effective method of preventing sexually transmitted human immunodeficiency virus (HIV) infections and has been instrumental in declining incidence rates. Adherence and access to HIV prevention still pose challenges due to stigma and …
The 2022 Clinical Practice Guideline for Prescribing Opioids for Pain, developed by the Centers for Disease Control and Prevention (CDC), was introduced as an update to the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain. This update aimed to …
Vaccination has long been recognized as one of the most effective public health interventions, preventing millions of deaths and significantly reducing the incidence of infectious diseases worldwide. Despite its success, vaccine hesitancy—a reluctance or delay in accepting vaccines despite availability—remains …
OVERVIEW Rheumatologists, pulmonologists, NPs, PAs, fellows and residents who have been in practice for less than 10 years with an interest in interstitial lung diseases (ILDs) are invited to attend the 2025 Early Career Professional Program on Interstitial Lung Disease (ECPP-ILD). …
Traditional diagnosis and treatment of Alzheimer’s disease (AD) has relied heavily on the clinical expertise of healthcare professionals (HCPs) and patient-reported symptoms. However, recently revised diagnostic criteria incorporate biomarkers—such as amyloid and tau pathology—and advanced imaging modalities, including amyloid, tau, …
Traditional diagnosis and treatment of Alzheimer’s disease (AD) has relied heavily on the clinical expertise of healthcare professionals (HCPs) and patient-reported symptoms. However, recently revised diagnostic criteria incorporate biomarkers—such as amyloid and tau pathology—and advanced imaging modalities, including amyloid, tau, …